Analyst Upgrades – GlaxoSmithKline (LON:GSK) Stock Gets Upgraded By Barclays from Overweight to

Analyst Ratings For GlaxoSmithKline (LON:GSK)

Story continues below

Today, GlaxoSmithKline (LON:GSK) stock received an upgrade by Barclays from Overweight with a price target of GBX 1,650.

Some recent analyst ratings include

  • 1/17/2018-Barclays Upgrade from a “Overweight” rating to a “” rating.
  • 1/16/2018-Jefferies Group Reiterated Rating of Buy.
  • 1/16/2018-BNP Paribas Reiterated Rating of Neutral.
  • 1/15/2018-Liberum Capital Reiterated Rating of Buy.
  • 12/13/2017-Berenberg Bank Reiterated Rating of Buy.

    Recent Trading Activity for GlaxoSmithKline (LON:GSK)
    Shares of GlaxoSmithKline closed the previous trading session at 1,364.60 up +9.60 0.71% with 38.189998626708984 shares trading hands.

    An ad to help with our costs